← Open Payments lookup

MARY HIGH: Open Payments

NPI 1457350019 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,673 in 93 payments from 16 companies in 2025. Trend: 2023 $1,532 · 2024 $1,847 · 2025 $1,673

Food & beverage: $1,673
CompanyPaymentsAmount
Novo Nordisk Inc19$360
Lilly USA, LLC10$184
GlaxoSmithKline, LLC.11$183
Astellas Pharma US Inc12$175
AstraZeneca Pharmaceuticals LP8$166
ABBVIE INC.9$150
Abbott Laboratories8$142
Exact Sciences Corporation3$57
IDORSIA PHARMACEUTICALS US INC2$50
PFIZER INC.2$50

Products named: Veozah, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, JARDIANCE, Rybelsus, MOUNJARO, Ozempic, FARXIGA.

Industry payments across DE — which companies pay providers there.